Gut microbiota, a new frontier to understand traditional Chinese medicines

W Feng, H Ao, C Peng, D Yan - Pharmacological Research, 2019 - Elsevier
As an important component of complementary and alternative medicines, traditional
Chinese medicines (TCM) are gaining more and more attentions around the world because …

Research progress on berberine with a special focus on its oral bioavailability

CS Liu, YR Zheng, YF Zhang, XY Long - Fitoterapia, 2016 - Elsevier
The natural product berberine (BBR) has become a potential drug in the treatment of
diabetes, hyperlipidemia, and cancer. However, the oral delivery of BBR is challenged by its …

Berberine, a plant alkaloid with lipid-and glucose-lowering properties: from in vitro evidence to clinical studies

A Pirillo, AL Catapano - Atherosclerosis, 2015 - Elsevier
Berberine (BBR) is an isoquinoline plant alkaloid endowed with several pharmacological
activities, including anti-microbial, glucose-and cholesterol-lowering, anti-tumoral and …

Transforming berberine into its intestine-absorbable form by the gut microbiota

R Feng, JW Shou, ZX Zhao, CY He, C Ma, M Huang… - Scientific Reports, 2015 - nature.com
The gut microbiota is important in the pathogenesis of energy-metabolism related diseases.
We focused on the interaction between intestinal bacteria and orally administered chemical …

[HTML][HTML] Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine

Y Wang, Q Tong, JW Shou, ZX Zhao, XY Li… - Theranostics, 2017 - ncbi.nlm.nih.gov
Nitroreductases (NRs) are bacterial enzymes that reduce nitro-containing compounds. We
have previously reported that NR of intestinal bacteria is a key factor promoting berberine …

A General Cp*CoIII‐Catalyzed Intramolecular C−H Activation Approach for the Efficient Total Syntheses of Aromathecin, Protoberberine, and Tylophora Alkaloids

A Lerchen, T Knecht, M Koy… - … –A European Journal, 2017 - Wiley Online Library
Herein, we report a Cp* CoIII‐catalyzed C− H activation approach as the key step to create
highly valuable isoquinolones and pyridones as building blocks that can readily be applied …

Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption

Y Wang, X Yi, K Ghanam, S Zhang, T Zhao, X Zhu - Metabolism, 2014 - Elsevier
Objective The objective was to determine the mechanisms of action of berberine (BBR) on
cholesterol homeostasis using in vivo and in vitro models. Methods Male Sprague–Dawley …

Learning from berberine: treating chronic diseases through multiple targets

J Yao, WJ Kong, JD Jiang - Science china life sciences, 2015 - Springer
Although advances have been made, chemotherapy for chronic, multifactorial diseases such
as cancers, Alzheimer's disease, cardiovascular diseases and diabetes is far from …

[HTML][HTML] A novel analgesic isolated from a traditional Chinese medicine

Y Zhang, C Wang, L Wang, GS Parks, X Zhang, Z Guo… - Current Biology, 2014 - cell.com
Background Current pain management is limited, in particular, with regard to chronic pain. In
an attempt to discover novel analgesics, we combined the approach developed to …

Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters

XY Li, ZX Zhao, M Huang, R Feng, CY He, C Ma… - Journal of translational …, 2015 - Springer
Background Berberine (BBR), as a new medicine for hyperlipidemia, can reduce the blood
lipids in patients. Mechanistic studies have shown that BBR activates the extracellular-signal …